BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22926300)

  • 1. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
    Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
    Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
    Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
    J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
    Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
    Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
    J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
    Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).
    Manjer J; Johansson R; Berglund G; Janzon L; Kaaks R; Agren A; Lenner P
    Cancer Causes Control; 2003 Sep; 14(7):599-607. PubMed ID: 14575357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
    Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
    Tymchuk CN; Tessler SB; Barnard RJ
    Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
    Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
    Costantino L; Catalano MG; Frairia R; Carmazzi CM; Barbero M; Coluccia C; Donadio M; Genta F; Drogo M; Boccuzzi G; Fortunati N
    Breast Cancer Res Treat; 2009 Apr; 114(3):449-56. PubMed ID: 18437557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
    Key T; Appleby P; Barnes I; Reeves G;
    J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.